Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics
ASRT Price/Volume Stats
| Current price | $1.27 | 52-week high | $3.05 |
| Prev. close | $1.27 | 52-week low | $0.73 |
| Day low | $1.25 | Volume | 290,800 |
| Day high | $1.28 | Avg. volume | 1,013,918 |
| 50-day MA | $1.35 | Dividend yield | N/A |
| 200-day MA | $1.07 | Market Cap | 120.81M |
ASRT Stock Price Chart Interactive Chart >
Assertio Therapeutics, Inc. (ASRT) Company Bio
Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.
Latest ASRT News From Around the Web
Below are the latest news stories about ASSERTIO HOLDINGS INC that investors may wish to consider to help them evaluate ASRT as an investment opportunity.
Pre-Surge Penny Picks: 3 Stocks to Buy Before They BoomInvesting in penny stocks can be a great way to unlock gains from your portfolio. |
With 51% ownership of the shares, Assertio Holdings, Inc. (NASDAQ:ASRT) is heavily dominated by institutional ownersKey Insights Institutions' substantial holdings in Assertio Holdings implies that they have significant influence over... |
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of DirectorsLAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced today that Sravan Emany has been appointed to the Company’s Board of Directors. As part of the appointment, Assertio has expanded its board to seven seats. Mr. Emany currently serves as the Chief Financial Offic |
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call TranscriptAssertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript November 8, 2023 Assertio Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $0.23. Operator: Good morning and welcome to the Assertio Holdings Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there […] |
Astra Space (ASTR) Stock Spikes 82% on Take-Private ProposalAstra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders. |
ASRT Price Returns
| 1-mo | 18.69% |
| 3-mo | 20.95% |
| 6-mo | 13.39% |
| 1-year | -54.32% |
| 3-year | 32.24% |
| 5-year | -76.65% |
| YTD | 18.69% |
| 2023 | -75.12% |
| 2022 | 97.25% |
| 2021 | 52.40% |
| 2020 | -71.39% |
| 2019 | -65.37% |
Continue Researching ASRT
Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...